ADMA BIOLOGICS, INC. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
ADMA BIOLOGICS, INC. (ADMA) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate · last filed 2019-03-13
- ADMA BIOLOGICS, INC. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- ADMA BIOLOGICS, INC. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2017 was $17.26M.
- ADMA BIOLOGICS, INC. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2016 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 12 month |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-13 |
| 2017-12-31 | $17.26M 10-K · filed 2019-03-13 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |